# Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis

> **NCT02141958** · PHASE1 · COMPLETED · sponsor: **Elias Matouk** · enrollment: 15 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Fenretinide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02141958
- **Lead sponsor:** Elias Matouk
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141958, "Safety Study of Fenretinide in Adult Patients With Cystic Fibrosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02141958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*